Real demand
It replaces DIY notebooks and clunky food-tracking apps for a concrete, ongoing need: finding trigger foods after diagnosis. But $750/month and a 2024 shutdown show real yet small demand.
Real-revenue cases
How I Started A Food Diary After My Autoimmune Disorder Diagnosis -
Real demandA UK founder with IBS built a three-month paper food-and-symptom diary with monthly review pages, sold worldwide to people managing digestive and chronic conditions, at $750/month.
- Primary source
- View original
01
Real-demand verdict
Consumers buy a physical diary outright, one-time payment, shipped from the UK worldwide; no subscription or software revenue.
DIY notebooks with hand-drawn tables, and food-tracking apps that demand tedious data entry.
02
Where the first customers came from
Not stated; the story only mentions sharing user stories via Instagram and the blog.
03
Tactics you can copy
- 01Build from your own diagnosis and treat 'nothing exists for me' as demand validation.
- 02Use Instagram and a blog to publish real user stories as the acquisition channel.
- 03Design for less input: track food, symptoms and non-food triggers like sleep and stress, not brand-level detail.
Moving it to an AI business
For AI builders: turn the log-review-spot-pattern loop into an AI app that auto-detects triggers instead of manual entry — a natural replacement for this paper diary; reuse the patient-community content play for acquisition.
04
Evidence and limits
Founder interview, self-reported
Revenue basis · Founder self-reported, unaudited (see source page)
What evidence is missing
$750/month is founder self-reported and unaudited; unclear if it is peak or average.
No unit sales, price, repeat-purchase rate or CAC, so unit economics can't be assessed.
The 2024 shutdown reason is unstated, so it's unclear whether demand or operations failed.